Platelet reactivity linked to risks in endovascular procedures

05/1/2013 | Healio

A study in the Journal of the American College of Cardiology found that increased on-treatment platelet reactivity was tied to a greater risk of adverse clinical events with peripheral endovascular procedures. Basing antiplatelet treatment levels on point-of-care tests could lead to better outcomes for patients, the authors said.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD